Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular pathology and future developments.

J J Going1, B A Gusterson

  • 1Department of Pathology, University of Glasgow, Glasgow Royal Infirmary. going@udcf.gla.ac.uk

European Journal of Cancer (Oxford, England : 1990)
|March 11, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer.

British journal of cancer·2015
Same author

The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer.

British journal of cancer·2014
Same author

Fibulin-2 is involved in early extracellular matrix development of the outgrowing mouse mammary epithelium.

Cellular and molecular life sciences : CMLS·2014
Same author

The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer.

British journal of cancer·2013
Same author

The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer.

British journal of cancer·2012
Same journal

Early-onset colorectal cancer across Europe: Burden, mechanisms, and health-system implications.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinical urgency of incidental findings in the first year of the 4-IN-THE-LUNG-RUN lung cancer screening program.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

European journal of cancer (Oxford, England : 1990)·2026
See all related articles

A molecular revolution is transforming pathology, with new technologies enhancing disease diagnosis, prognosis, and treatment targeting. Integrating these advanced molecular methods with traditional pathology is crucial for future advancements in the genome era.

Area of Science:

  • Pathology
  • Molecular Biology
  • Genomics

Background:

  • Current pathology utilizes molecular techniques like in situ hybridization and immunocytochemistry for single gene analysis.
  • Emerging molecular technologies are poised to drive a significant revolution in pathology.

Purpose of the Study:

  • To highlight the imminent impact of advanced molecular technologies on pathology.
  • To discuss the potential of these technologies in oncology, disease susceptibility assessment, and refining screening.
  • To emphasize the importance of integrating molecular approaches with classical pathology.

Main Methods:

  • Polymerase chain reaction (PCR) advancements
  • Oligonucleotide and cDNA arrays for multi-gene expression studies
  • Serial analysis of gene expression (SAGE)

Related Experiment Videos

  • Expressed sequence tag (EST) sequencing
  • Comparative genomic hybridization
  • Multiplex fluorescence in situ hybridization (FISH)
  • Laser microdissection and bio-informatics

    • Main Results:

    • Molecular methods promise profound changes in cancer diagnosis, prognosis, and targeted therapy.
    • These technologies will enable assessment of individual disease susceptibility and improve screening protocols.
    • The integration of molecular biology with classical pathology is expected to yield the most significant benefits.

    Conclusions:

    • The application of emergent molecular technologies represents a paradigm shift in pathology.
    • Collaboration between molecular and classical pathology approaches is essential for comprehensive understanding and application.
    • Ensuring global accessibility to these advanced technologies is a key challenge for the biomedical community.